Top of this page
Skip navigation, go straight to the content

Newsroom Overview
 

Newsroom

image description
 

Press Release

Acquisitions and disposals of own shares10 Aug 2020

Acquisitions and disposals of own shares

Read more
CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum05 Aug 2020

CIMZIA[®] is the First and Only Biologic Approved in Europe …

Read more
Acquisitions and disposals of own shares30 Jul 2020

Acquisitions and disposals of own shares

Read more
 

UCB Stories

Exevir Bio 10 Aug 2020

ExeVir Bio: Collaborating and contributing to the fight against the …

Read more
27 Jul 2020

Resilient product portfolio drives continued company growth

Read more
24 Jul 2020

Differentiating symptoms of Parkinson’s and PSP: Is wearable technology …

Read more

Social Media